Records containing: Myeloproliferative Neoplasm
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-02-16Phase I Clinical Trial Using an Engineered Peripheral Blood Graft for Haploidentical Transplantation
-
CLINICAL_TRIALS study record update · 2023-02-13Being Present-MPN: A Distress Reduction Intervention for Patients With BCR-ABL-Negative MPNs and CML on Tyrosine Kinase Inhibitors
-
CLINICAL_TRIALS study record update · 2023-01-31Tacrolimus, Mini-dose Methotrexate and Mycophenolate Mofetil Versus Tacrolimus and Methotrexate for the Prevention of Acute Graft-versus-Host-Disease
-
CLINICAL_TRIALS study record update · 2023-01-04Effects of Prebiotics on Gut Microbiome in Patients Undergoing Stem Cell Transplants
-
CLINICAL_TRIALS study record update · 2022-10-31A Phase I Study of PLX51107 (A Novel Bromodomain Inhibitor) in Combination With Azacytidine for Patients With Myelodysplastic Syndrome and Acute Myeloid Leukemia (AML)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-10-18Observational Study of the Impact of the COronaVirus Disease 2019 (COVID-19) Epidemic on Patients With Myeloproliferative Neoplasias
-
CLINICAL_TRIALS study record update · 2022-10-06Evaluation of New Biomarkers of Thrombosis in Myeloproliferative Neoplasms
-
CLINICAL_TRIALS study record update · 2022-08-30A Study of Olverembatinib in the Treatment of Myeloid/Lymphoid Tumors With FGFR1 Rearrangement
-
CLINICAL_TRIALS study record update · 2022-06-22A Randomized Clinical Trial to Assess the Impact of a Remotely Administered Diet Intervention on Symptom Burden and Inflammatory Cytokines in Myeloproliferative Neoplasm: Feasibility Phase
-
CLINICAL_TRIALS study record update · 2022-04-05An Observational Study to Collect and Assess Tissue Samples From Subjects With One of Three Neoplastic Conditions (ANSWer)
-
CLINICAL_TRIALS study record update · 2021-09-16A Study Assessing Morbidity and Portal Circulation in Patients With Myeloproliferative Neoplasms and Splanchnic Vein Thrombosis
-
CLINICAL_TRIALS study record update · 2021-08-11Targeting TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia (AML) With Azacitidine and Ascorbic Acid
-
CLINICAL_TRIALS study record update · 2021-06-30A Randomized Phase II Study to Compare ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2021-06-24Post Transplant Infusion of Allogeneic CD8 Memory T-Cells as Consolidative Therapy After Non-myeloablative Allogeneic Hematopoietic Cell Transplantation in Patients With Leukemia and Lymphoma
-
CLINICAL_TRIALS study record update · 2021-06-24A Phase I/IB Study of Ipilimumab or Nivolumab in Patients With Relapsed Hematologic Malignancies After Allogeneic Hematopoietic Cell Transplantation
-
CLINICAL_TRIALS study record update · 2021-05-19Phase I, Interventional, Single Arm, Open Label, Treatment Study to Evaluate The Safety and Tolerability of CLL1-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies.
-
CLINICAL_TRIALS study record update · 2021-02-25A Phase 1b/2 Study to Evaluate the Safety and Efficacy of APR-246 in Combination With Azacitidine for the Treatment of TP53 Mutant Myeloid Neoplasms
-
CLINICAL_TRIALS study record update · 2021-02-21Use of Direct Oral Anticoagulants (DOACs) in Patients With Ph-negative Myeloproliferative Neoplasms
-
CLINICAL_TRIALS study record update · 2020-11-17Sequential and Personalized Pharmacokinetic-guided Busulfan Administration in the Frame of the Conditiong Regimen for Allogeneic Haematopoietic Stem Cell Transplantation in Patients With Malignant Hemopathies Ineligible for the Standard Myeloablative Conditioning
-
CLINICAL_TRIALS study record update · 2020-10-14A Phase I Study of Pomalidomide Given at the Time of Lymphocyte Recovery Following Induction Timed Sequential Chemotherapy With Cytarabine, Daunorubicin and Etoposide (AcDVP16) in Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) and High-Risk MDS
-
CLINICAL_TRIALS study record update · 2020-08-27Anticoagulation Treatment of Patients With Gastroesophageal Varices and JAK2 V617 Mutation
-
CLINICAL_TRIALS study record update · 2020-08-25Characteristic of Patients With Gastroesophageal Varices and Portal Cavernoma
-
CLINICAL_TRIALS study record update · 2020-08-14Phase I Trial With "Off-The-Shelf" Third-Party BPX-501 Donor Lymphocyte Immunotherapy to Treat Persistence or Relapse of Hematologic Malignancies After Allogeneic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2020-03-18Value of CD26 Positive Stem Cell Marker in Patients With Classical Myeloproliferative Neoplasms
-
CLINICAL_TRIALS study record update · 2020-01-30A Phase 1b/2 Study to Evaluate the Safety and Efficacy of APR-246 in Combination With Azacitidine for the Treatment of Mutation TP53 (TP53) Mutant Myeloid Neoplasms